New regenerative tear trough injectable could reshape under eye care
A new investigational tear trough injectable that targets tissue regeneration, not just volume, has entered Phase 2 FDA trials. Here is what this under eye breakthrough could mean for people dealing with hollowing and shadows, especially in a bright, dry climate like Las Vegas.
Key takeaways
- A new investigational injectable for tear troughs (rhPDGF-BB) has FDA clearance to begin a Phase 2b trial focused on regenerating under eye tissue rather than simply filling it.
- This trial will look at safety, under eye hollowing at 12 weeks, changes in tissue quality, and how the product behaves in the body across about 75 adult participants.
- Regenerative injectables could eventually offer an alternative for people who are not ideal candidates for traditional hyaluronic acid fillers in the under eye area, though they are not yet approved or available for cosmetic use.
- Anyone considering under eye treatment today should still focus on proven options, realistic expectations, and choosing a qualified provider who uses FDA approved products and safe techniques.
What is this new regenerative tear trough injectable everyone is talking about?
A fresh development in under eye aesthetics just stepped into the spotlight: an investigational injectable designed to help the body rebuild tissue in the tear trough area, not simply plump it up. Lynch Regenerative Medicine has received FDA clearance to run a Phase 2b clinical trial of a product based on recombinant human platelet-derived growth factor-BB, often abbreviated as rhPDGF-BB. Instead of acting like a classic hyaluronic acid filler that primarily replaces lost volume, this molecule belongs to a category sometimes called regenerative or biostimulatory treatments. The idea is that specific growth factors can encourage the body to repair or remodel its own tissues over time.
Right now, this product is not something you can book at your local med spa. It is still in the research stage and available only inside controlled clinical trials. The Phase 2b study will follow about 75 adult participants who have visible hollowness under the eyes, and it will carefully measure how their tear troughs change after treatment. Researchers will track not only appearance at around the 12-week mark but also tissue quality and deeper safety markers. For people in image-conscious cities like Las Vegas, where bright sun, late nights and desert dryness can make under eye concerns especially noticeable, this kind of future option naturally grabs attention.
- Regenerative injectables aim to help the body repair tissue over time
- The product in this trial is based on rhPDGF-BB, a lab-made growth factor
- The focus is the tear trough or infraorbital hollow under the eyes
- It is in research only and not available for routine cosmetic use
How does a regenerative under eye injectable differ from traditional filler?
Most people who ask about their tear troughs now are offered hyaluronic acid filler, because it is reversible and has an immediate volumizing effect. These gels work by physically taking up space under the skin, drawing in water, and softening the transition from lower eyelid to cheek. When placed by a skilled injector, they can reduce the look of dark shadows that come from structural hollowness. However, not everyone is an ideal candidate. Some people experience puffiness, a bluish tint, or uneven texture if filler is not matched well to their anatomy or if the product draws too much water.
Regenerative injectables like the rhPDGF-BB product being studied are built around a different concept. Instead of acting as a long-lasting gel, the active ingredient is a signaling protein that can encourage nearby cells to grow, repair, or remodel tissue. In theory, that may mean more gradual changes in the way the under eye skin and supporting structures behave, possibly improving texture and quality along with contour. The Phase 2 trial will examine not only how hollowing looks on the surface, but also imaging of the tissues and laboratory markers that show how the product behaves in the body. At this point, we do not know if it will outperform fillers, work best as a partner treatment, or end up useful only for a subset of people.
- Fillers replace or add volume right away under the skin
- Regenerative products aim to stimulate the body’s own repair processes
- Fillers are gel-based, while rhPDGF-BB is a signaling protein
- Results from regenerative treatments are expected to be gradual, not instant
What is this Phase 2b tear trough trial actually testing?
When the FDA clears a Phase 2b study, it means the product has passed early lab and safety steps and is ready to be tested in a larger, more structured way in humans. In this case, the rhPDGF-BB tear trough injectable will be studied in a randomized, dose-ranging trial across multiple clinical sites. Around 75 adults with infraorbital hollowing will receive different doses or possibly a comparison treatment, so researchers can see which approach gives the best balance of effect and safety. The central outcome they care about is how much the under eye hollows improve at about 12 weeks after treatment.
The trial is not simply about looking at before-and-after photos. Investigators will also track changes in tissue quality, use imaging tools to see what is happening below the skin surface, and monitor for any immune reactions to the lab-made growth factor. Measuring pharmacokinetics means they will follow how the drug moves through and leaves the body over time. All of this data helps regulators decide whether the product is safe enough and effective enough to continue into larger Phase 3 studies. Until those steps are complete and reviewed, no one can say whether this injectable will ever become a mainstream option at med spas in Las Vegas or elsewhere.
- About 75 adults with visible under eye hollowing will enroll
- Researchers will study multiple doses to find a useful range
- The main goal is to see improvement in tear trough appearance at 12 weeks
- Safety, imaging, immune reactions, and drug levels will also be tracked
Who might one day benefit from a regenerative tear trough treatment?
Although the product is still in testing, it sparks a common question: who could this eventually help if it proves safe and effective? Many people are bothered by under eye shadows and hollows that do not respond to more sleep or topical eye creams. Genetics, bone structure, fat loss with age, and volume changes from weight loss drugs can all make the orbital area look more sunken. Under the intense desert sun in Las Vegas, shadows can appear deeper, especially when makeup settles into fine lines. For some, standard filler works beautifully, but for others it can look puffy, uneven, or simply not quite right.
In the future, a regenerative option might be interesting for people who have thinner skin or more delicate tissue under the eyes and are hesitant about adding more gel-based volume. Some may prefer a gradual change that focuses on tissue quality rather than instant fullness. It might also appeal to those looking for a more subtle, "did they or didn’t they" shift instead of dramatic correction. However, there are many unknowns: which skin types respond best, how long any improvements last, and whether it pairs well with other treatments like laser resurfacing or microneedling around the eyes. For now, these questions are why controlled clinical trials exist.
What should you do about under eye hollows while this treatment is still in trials?
If you are bothered by tired-looking eyes today, you do not have to wait for future technologies to feel more confident. Proven options already exist, and a thoughtful consultation can help you sort through them. Hyaluronic acid filler placed conservatively in the tear trough or midface is one route. For others, the answer might be skin-focused: gentle laser, radiofrequency microneedling, chemical peels, or prescription skincare to improve texture and fine lines that exaggerate hollows. Sometimes changes in sleep, hydration, and allergies can reduce swelling and darkness that make hollows more striking. In a dry climate like Las Vegas, simply optimizing barrier-supporting skincare and sun protection around the eyes can make a visible difference over time.
The key is to focus on safety and personalization. Under eye treatments require a deep understanding of anatomy, because the skin is thin and the area is close to the eyes and blood vessels. Choosing a provider who uses only FDA approved products and follows strict injection protocols is essential. Recent public health reports about complications from unapproved toxins and contaminated wellness injections serve as a reminder that product quality and technique are not optional details. While regenerative injectables are being studied, your best move is to work with a qualified professional who can walk you through current options, risks, and likely timelines based on your unique features.
How does this fit into the bigger trend toward regenerative aesthetics?
The tear trough trial is part of a broader shift in aesthetics toward treatments that nudge your body to do more of the work. In recent years, there has been growing interest in biostimulatory fillers, platelet-rich plasma, exosome-based skincare, and energy devices that stimulate collagen instead of relying solely on external volume. A regenerative injectable for the under eye fits right into this pattern. Consumers are asking for results that look like themselves on a good day, rather than a completely different face. They are also interested in treatments that focus on skin quality and structure, not just temporary plumping.
At the same time, the move toward regeneration requires even tighter safety standards. When you are influencing how cells behave, regulators want to be sure there are no unexpected side effects, such as abnormal tissue growth or immune problems. That is why trials like this tear trough study include careful imaging, lab work, and long follow-up windows. For people in busy, beauty-focused cities like Las Vegas, it can be tempting to chase every new headline. A better strategy is to watch how new technologies progress through trials, ask your provider pointed questions about evidence, and combine tried-and-true treatments with emerging options only once they are proven and approved.
How to talk with your provider about under eye options in a fast-evolving landscape
News about a regenerative tear trough injectable is a great prompt to review your own goals and questions before your next consult. Start by getting specific about what bothers you: is it dark pigment, actual hollowness, puffiness, fine lines, or some mix of all four? Each concern calls for a different toolkit. Bring reference photos of how your eyes looked in earlier years or on days when you like them more. This helps your provider see what “natural” means for you. Be honest about your tolerance for downtime, how far you are willing to travel for follow-ups, and what you absolutely do not want, such as looking puffy or "overdone."
Use the consult to ask clear safety and product questions too. Ask which brands and product types your provider uses under the eyes and whether they are FDA approved for any area of the face. Discuss what is known and not known about long-term behavior of each option, including fillers that can last a year or more. You can also ask how your provider stays current on emerging treatments like regenerative injectables and how they decide when something is established enough to offer. A good aesthetic plan usually combines sun protection, skincare, and in-office treatments rather than relying on a single injectable to fix everything. If you are in the Las Vegas area and curious about how all of this might apply to your own under eye concerns, you can always book a consultation at our med spa to talk through personalized, current options.
- Ask your provider to explain the difference between volume replacement (fillers) and regenerative approaches, so you understand which strategy is being used on your under eyes today.
- If you hear about new injectables on social media, verify that they are FDA approved for cosmetic use in the United States rather than assuming a trending name is widely available or vetted.
- Schedule a consult specifically focused on the eye area, and come prepared to discuss your sleep patterns, allergies, screen time, and skincare, all of which can impact how your tear troughs look.
- Request that your injector show you before-and-after photos of patients with similar under eye anatomy and concerns instead of generic examples that may not match your features.
- Build an eye-safe skincare routine that includes gentle cleansing, a hydrating eye product, and broad-spectrum SPF applied carefully around, not into, the eyes to protect this delicate zone.
- If you are not ready for injectables, ask about noninvasive treatments such as light-based therapies, microneedling, or peels tailored to the lower eyelid and cheek junction.
- Check that any clinic you visit uses only FDA approved or appropriately compounded products sourced through legitimate channels, and do not hesitate to ask where their injectables come from.
- Revisit your under eye plan once or twice a year, because your bone structure, facial fat, weight, and lifestyle can change, and the best treatment mix often changes along with them.
- Stay cautious about traveling deals or pop-up events for under eye injections, and prioritize clinics that emphasize assessment, safety, and follow-up rather than quick, one-size-fits-all treatments.
Frequently Asked Questions
What is a regenerative tear trough injectable and how is it different from regular under eye filler?
A regenerative tear trough injectable uses a growth factor-based ingredient, like rhPDGF-BB, that aims to encourage your own tissues to repair or remodel. Traditional fillers use gel-like materials such as hyaluronic acid that immediately add volume under the skin. With a regenerative option, results would likely be more gradual and focused on tissue behavior instead of just adding fullness. The investigational product in the news is still in clinical trials and not available for routine cosmetic use.
Is the new rhPDGF-BB tear trough injectable available at med spas yet?
No, the rhPDGF-BB tear trough injectable is not available for general cosmetic treatment at this time. The FDA has allowed it to move into a Phase 2b clinical trial, which is a research step to evaluate safety and early effectiveness. Only enrolled participants at specific study sites can receive it under strict protocols. It would still need to clear larger trials and regulatory review before entering regular practice, if it does so at all.
Could a regenerative under eye injectable be safer than traditional filler?
It is too early to say whether a regenerative under eye injectable will be safer or riskier than current fillers. The purpose of the current trial is to gather detailed safety data, including immune reactions, tissue changes, and how the drug moves through the body. Traditional hyaluronic acid fillers have a known safety profile when used by experienced injectors, but they can still cause complications. Any new product must be compared carefully against that track record before it is offered widely.
What are my options if I want to treat under eye hollows right now?
Today, common options for under eye hollows include conservative hyaluronic acid filler, cheek or midface filler to support the area, skin-resurfacing treatments, and medical-grade skincare. Some people also benefit from addressing lifestyle factors such as poor sleep, allergies, or dehydration that make the area look worse. A qualified provider can assess whether your main issue is hollowing, puffiness, pigment, or texture and then suggest a combination of treatments tailored to you.
How do I know if I am a good candidate for tear trough filler or other under eye treatments?
You are more likely to be a candidate if you have true volume loss or a visible groove between your lower eyelid and cheek, rather than mainly puffiness or loose skin. During a consultation, a provider will examine your bone structure, fat pads, skin thickness, and blood vessels in the area. They will also review your health history and any previous procedures. Based on this, they can suggest filler, alternative treatments, or in some cases refer you for a surgical opinion if that is more appropriate.
What should I ask my provider about new under eye injectables and safety?
Ask which specific products they use under the eyes and whether each one is FDA approved, and if not, why they feel it is appropriate. Request information about potential side effects, how complications are managed, and what follow-up care looks like. You can also ask how they stay informed about new options like regenerative injectables and at what point they feel comfortable adding a new technology to their practice. A transparent, evidence-based answer is a good sign that safety is a priority.
Sources
- Lynch Regenerative Medicine secures FDA clearance for Phase 2 trial of regenerative tear trough injectable — Medical Aesthetics News (ValuraNova)
- Investigation of Unapproved Botulinum Toxin Product Administered at a Medical Spa, Colorado, 2025-2026 — Centers for Disease Control and Prevention
- Three Colorado Women Developed Blurred Vision and Weakness After Unapproved Botulinum Toxin Shots at a Medical Spa — MedicalDaily
- Adverse Events Linked to Injectable Glutathione Compounded with Dietary Supplement Grade Ingredient: Current Situation — Centers for Disease Control and Prevention